Tusslin (dextromethorphan Hbr recalls

The FDA has published 1 recall involving Tusslin (dextromethorphan Hbr since 2019. The latest was reported on 31 Jul 2019. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 31 Jul 2019

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tusslin (dextromethorphan hbr is recalled

Potency & Assay1100%

Companies

Pharma-Natural1100%

By year

20191100%

All tusslin (dextromethorphan hbr recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
31 Jul 2019Drug	CLASS II	Tusslin (Dextromethorphan HBr, 28 mg; Guaifenesin, 388 mg recalled	Pharma-Natural	Potency & Assay	Nationwide

Should you stop taking Tusslin (dextromethorphan Hbr?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.